Shares of Doximity, Inc. (NASDAQ:DOCS – Get Free Report) have received an average recommendation of “Hold” from the fifteen analysts that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating on the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $28.73.
A number of equities research analysts have weighed in on the stock. JPMorgan Chase & Co. raised shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 target price on the stock in a report on Thursday, April 25th. Needham & Company LLC reaffirmed a “hold” rating on shares of Doximity in a report on Friday, May 17th. William Blair reissued an “outperform” rating on shares of Doximity in a research note on Friday, May 17th. Evercore ISI upped their target price on Doximity from $28.00 to $29.00 and gave the company an “in-line” rating in a report on Friday, May 17th. Finally, Morgan Stanley restated an “underweight” rating and set a $25.00 price target on shares of Doximity in a report on Tuesday, April 23rd.
View Our Latest Research Report on Doximity
Insider Activity
Hedge Funds Weigh In On Doximity
A number of hedge funds have recently added to or reduced their stakes in DOCS. Apella Capital LLC boosted its position in shares of Doximity by 16.5% during the second quarter. Apella Capital LLC now owns 54,589 shares of the company’s stock valued at $1,494,000 after buying an additional 7,746 shares during the last quarter. DekaBank Deutsche Girozentrale bought a new position in Doximity during the 1st quarter valued at $46,000. Swedbank AB purchased a new position in Doximity during the 1st quarter worth $91,673,000. LRI Investments LLC bought a new stake in shares of Doximity in the 1st quarter worth $27,000. Finally, Virtu Financial LLC purchased a new stake in shares of Doximity in the first quarter valued at about $223,000. Institutional investors and hedge funds own 87.19% of the company’s stock.
Doximity Stock Performance
Shares of DOCS opened at $27.08 on Friday. The stock has a market capitalization of $5.02 billion, a price-to-earnings ratio of 37.61, a PEG ratio of 5.08 and a beta of 1.22. Doximity has a 52 week low of $19.71 and a 52 week high of $36.29. The stock has a fifty day moving average of $27.15 and a 200-day moving average of $27.46.
Doximity (NASDAQ:DOCS – Get Free Report) last posted its earnings results on Thursday, May 16th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.16 by $0.04. The firm had revenue of $118.06 million during the quarter, compared to the consensus estimate of $116.46 million. Doximity had a return on equity of 17.44% and a net margin of 31.04%. As a group, equities analysts forecast that Doximity will post 0.74 EPS for the current year.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Read More
- Five stocks we like better than Doximity
- What is the Dow Jones Industrial Average (DJIA)?
- Sales Breakout Sends This Semiconductor Stock to Record High
- Breakout Stocks: What They Are and How to Identify Them
- Surprise Buying Opportunity on This Dividend Aristocrat
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.